Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

29 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Novel fusion between the breakpoint cluster region and platelet-derived growth factor receptor-alpha genes in a patient with chronic myeloid leukemia-like neoplasm: undetectable residual disease after imatinib therapy.
Cluzeau T, Lippert E, Cayuela JM, Maarek O, Migeon M, Noguera ME, Dombret H, Rea D. Cluzeau T, et al. Among authors: maarek o. Eur J Haematol. 2015 Nov;95(5):480-3. doi: 10.1111/ejh.12576. Epub 2015 May 20. Eur J Haematol. 2015. PMID: 25941032
Report of 34 patients with clonal chromosomal abnormalities in Philadelphia-negative cells during imatinib treatment of Philadelphia-positive chronic myeloid leukemia.
Terre C, Eclache V, Rousselot P, Imbert M, Charrin C, Gervais C, Mozziconacci MJ, Maarek O, Mossafa H, Auger N, Dastugue N, Talmant P, Van den Akker J, Leonard C, N'Guyen Khac F, Mugneret F, Viguié F, Lafage-Pochitaloff M, Bastie JN, Roux GL, Nicolini F, Maloisel F, Vey N, Laurent G, Recher C, Vigier M, Yacouben Y, Giraudier S, Vernant JP, Salles B, Roussi J, Castaigne S, Leymarie V, Flandrin G, Lessard M; France Intergroupe pour la Leucemie Myeloide Chronique. Terre C, et al. Among authors: maarek o. Leukemia. 2004 Aug;18(8):1340-6. doi: 10.1038/sj.leu.2403399. Leukemia. 2004. PMID: 15190256
Phase 2 clinical trial of 5-azacitidine, valproic acid, and all-trans retinoic acid in patients with high-risk acute myeloid leukemia or myelodysplastic syndrome.
Raffoux E, Cras A, Recher C, Boëlle PY, de Labarthe A, Turlure P, Marolleau JP, Reman O, Gardin C, Victor M, Maury S, Rousselot P, Malfuson JV, Maarek O, Daniel MT, Fenaux P, Degos L, Chomienne C, Chevret S, Dombret H. Raffoux E, et al. Among authors: maarek o. Oncotarget. 2010 May;1(1):34-42. doi: 10.18632/oncotarget.106. Oncotarget. 2010. PMID: 21293051 Free PMC article. Clinical Trial.
Sustained major molecular response in the absence of any antileukaemic therapy after dasatinib treatment and autologous peripheral blood stem cell transplantation in a patient with imatinib-resistant myeloblastic-phase chronic myeloid leukaemia.
Rea D, Raffoux E, Cayuela JM, Maarek O, Dombret H. Rea D, et al. Among authors: maarek o. Leukemia. 2009 Jun;23(6):1158-9. doi: 10.1038/leu.2008.376. Epub 2009 Jan 8. Leukemia. 2009. PMID: 19151779 No abstract available.
Undetectable molecular residual disease after omacetaxine and nilotinib combination therapy in an imatinib-resistant chronic myeloid leukaemia patient harbouring the BCR-ABL1 T315I gatekeeper mutation.
Coude MM, Luycx O, Cariou ME, Maarek O, Dombret H, Cayuela JM, Rea D. Coude MM, et al. Among authors: maarek o. Br J Haematol. 2012 May;157(3):407-10. doi: 10.1111/j.1365-2141.2011.09016.x. Epub 2012 Jan 9. Br J Haematol. 2012. PMID: 22225474 Free article. No abstract available.
Transplantation for Fanconi's anaemia: long-term follow-up of fifty patients transplanted from a sibling donor after low-dose cyclophosphamide and thoraco-abdominal irradiation for conditioning.
Socié G, Devergie A, Girinski T, Piel G, Ribaud P, Esperou H, Parquet N, Maarek O, Noguera MH, Richard P, Brison O, Gluckman E. Socié G, et al. Among authors: maarek o. Br J Haematol. 1998 Oct;103(1):249-55. doi: 10.1046/j.1365-2141.1998.00968.x. Br J Haematol. 1998. PMID: 9792317 Free article.
Long-term complete haematological and molecular remission after allogeneic bone marrow transplantation in a patient with a stem cell myeloproliferative disorder associated with t(8;13)(p12;q12).
Suzan F, Guasch G, Terre C, Garcia I, Bastie JN, Maarek O, Ribaud P, Gluckman E, Daniel MT, Pébusque MJ, Castaigne S. Suzan F, et al. Among authors: maarek o. Br J Haematol. 2003 Apr;121(2):312-4. doi: 10.1046/j.1365-2141.2003.04269.x. Br J Haematol. 2003. PMID: 12694254 Free article.
29 results